Långström N S, Eriksson A, Winblad B G, Wallace W C
Department of Psychiatry and Fishberg Center for Neurobiology, Mount Sinai School of Medicine, New York, N.Y., U.S.A.; Department of Geriatric Medicine, Karolinska Institute, Huddinge University Hospital, S-14186 Huddinge, Sweden.
Neurochem Int. 1990;16(2):147-56. doi: 10.1016/0197-0186(90)90082-5.
To assess their suitability for studies of translational regulation of gene expression, cytosolic polyribosomes (polysomes) were purified from human postmortem frontal cortex and cerebellum. Human polysomes from 11 individual brains of various ages, postmortem intervals and agonal states were compared to polysomes purified from rat whole brains for yield, size and translational activity. Similar yields (mean +/- SD: 1.65 +/- 0.4 A(260) units/g tissue) of frontal cortical polysomes were obtained from the various human brain frontal cortices independent of age, postmortem interval and agonal state. The yields from the young rat brains were 2.5-fold greater. Polysomes containing up to 6 ribosomes per mRNA molecule were reproducibly purified from the human tissue whereas the rat polysomes were larger, containing 15-20 ribosomes per message. The human polysomes were less translationally efficient than rat (means +/- SD: 730 +/- 170 x 10(3) vs 5800 +/- 700 x 10 (3) dpm [ (35)S]methionine/A (260)unit ) which is consistent with the larger sizes of the rat polysomes and the inability of the human polysomal mRNA to reinitiate in the assay. Neither polysome sizes nor translational efficiency were dependent on age, postmortem interval and agonal state. However, the relative rates of elongation by total rat and human polysome populations were similar. The rat and human polysomes synthesized polypeptides of similar size ranges which indicates that similarly sized mRNAs were associated with the polysomes. Thus, utilizing the described methodology, intact and translationally active polysomes have been reproducibly isolated from various human postmortem brain tissues. The polysomes may be used to investigate translational control of gene expression in the human brain during normal and neuropathological conditions.
为了评估其在基因表达翻译调控研究中的适用性,从人类死后的额叶皮质和小脑中纯化了胞质多核糖体(多聚核糖体)。将来自11个不同年龄、死后间隔和濒死状态的个体大脑的人类多聚核糖体与从大鼠全脑中纯化的多聚核糖体在产量、大小和翻译活性方面进行了比较。从不同的人类大脑额叶皮质中获得的额叶皮质多聚核糖体产量相似(平均值±标准差:1.65±0.4 A260单位/克组织),与年龄、死后间隔和濒死状态无关。幼鼠大脑的产量高2.5倍。从人类组织中可重复纯化出每个mRNA分子含有多达6个核糖体的多聚核糖体,而大鼠多聚核糖体更大,每个信息含有15 - 20个核糖体。人类多聚核糖体的翻译效率低于大鼠(平均值±标准差:730±170×10³对5800±700×10³ dpm [³⁵S]甲硫氨酸/A260单位),这与大鼠多聚核糖体更大以及人类多聚体mRNA在测定中无法重新起始一致。多聚核糖体大小和翻译效率均不依赖于年龄、死后间隔和濒死状态。然而,大鼠和人类多聚核糖体总体的相对延伸率相似。大鼠和人类多聚核糖体合成的多肽大小范围相似,这表明大小相似的mRNA与多聚核糖体相关联。因此,利用所描述的方法,已从各种人类死后脑组织中可重复地分离出完整且具有翻译活性的多聚核糖体。这些多聚核糖体可用于研究正常和神经病理条件下人类大脑中基因表达的翻译控制。